Editor’s note: This story was updated at 4:28 p.m. March 29, 2022 — The FDA said Tuesday that it approved fourth doses of COVID-19 vaccines for many Americans to protect the most vulnerable people against severe COVID-19 illness, hospitalization, and death. According to an FDA news release, anyone over 50, and people over 18 who … Read more
Moderna said in the coming weeks it would ask regulators in the U.S. and Europe to authorize two small-dose shots for youngsters under 6. Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday — and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by … Read more
Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday — and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer. Moderna said in the coming weeks it would ask regulators in the U.S. and Europe to authorize two small-dose shots for youngsters under … Read more
Feb. 14, 2022 Booster shots of the Pfizer/BioNTech and Moderna COVID-19 vaccines lost some effectiveness after four months but still did a good job of keeping people out of the hospital during the Omicron surge, a study shows. During the time when the Omicron variant dominated, the vaccines provided 87% effectiveness against emergency room visits … Read more
By Robin Foster HealthDay Reporter THURSDAY, Jan. 27, 2022 (HealthDay News) — Moderna Inc. announced Wednesday that it has launched a trial that will study the power of a redesigned booster shot — one that hones in on the highly contagious Omicron variant. The news comes just one day after Pfizer … Read more
Bancel said the best case scenario was the combined COVID/flu vaccine would be available by the fall of 2023, at least in some countries. Moderna Inc’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around … Read more
According to US Centers for Disease Control and Prevention data, over 99.5% of infections in the country in November were caused by the Delta variant. As the world still comes to grips with coronavirus’ variant, said to be highly transmissible if not deadlier than the Delta variant, that has dimmed the chances of a pandemic-free … Read more
Moderna on Monday announced that a booster dose of its COVID-19 vaccine increased levels of antibodies that fight the Omicron variant. Source link
Moderna said lab tests showed the half-dose booster shot increased by 37 times the level of so-called neutralizing antibodies able to fight omicron. Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant. Moderna said lab tests showed the half-dose booster shot increased by 37 … Read more
Dec. 10, 2021 — The effectiveness of the two most common COVID-19 vaccines declined over time in an older group of patients, suggesting that booster doses may be needed to protect recipients over the long term, according to a new study. Also seen in that group of U.S. veterans, who had a median age of … Read more